|
ARHGAP42 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.324210E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.040300E-02 |
| Normal-vs-Stage2 |
4.127200E-01 |
| Normal-vs-Stage3 |
6.866600E-01 |
| Normal-vs-Stage4 |
6.884000E-01 |
| Stage1-vs-Stage2 |
6.770600E-01 |
| Stage1-vs-Stage3 |
1.738600E-01 |
| Stage1-vs-Stage4 |
3.461700E-02 |
| Stage2-vs-Stage3 |
5.805200E-01 |
| Stage2-vs-Stage4 |
2.880000E-01 |
| Stage3-vs-Stage4 |
4.828600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.706600E-01 |
| Normal-vs-AfricanAmerican |
4.822000E-02 |
| Normal-vs-Asian |
4.812000E-01 |
| Caucasian-vs-AfricanAmerican |
8.883900E-02 |
| Caucasian-vs-Asian |
9.771200E-01 |
| AfricanAmerican-vs-Asian |
1.120440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.642800E-01 |
| Normal-vs-Female |
5.359800E-02 |
| Male-vs-Female |
4.461700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.853800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.574800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.815400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.816830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.438000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.247800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.839950E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.638800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.936300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.729200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.062600E-03 |
| Classical-VS-Follicular |
3.456300E-02 |
| Classical-VS-Other |
3.068200E-01 |
| Classical-VS-Normal |
1.652370E-02 |
| Tall-VS-Follicular |
6.909600E-01 |
| Tall-VS-Other |
8.328200E-01 |
| Tall-VS-Normal |
6.469400E-01 |
| Follicular-VS-Other |
7.702400E-01 |
| Follicular-VS-Normal |
9.805000E-01 |
| Other-VS-Normal |
6.462200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.583600E-01 |
| Normal-vs-N1 |
8.582000E-01 |
| N0-vs-N1 |
3.382200E-01 |
|
|
